Breaking News

Toxikon Expands ESRS

Preclinical CRO begins construction on expanded Efficacy and Ssurgical Research Services wing

By: Gil Roth

President, Pharma & Biopharma Outsourcing Association

Toxikon Corp. is moving forward with a plan to expand a portion of its Bedford, MA campus for its Efficacy and Surgical Research Services. The expansion is expected to be complete in August and will include accommodations for more animal model development, trainings, demonstrations, and remote visualization of procedures and surgeries. According to the company, the modifications will provide Toxikon’s research and product development clientele with resources and scientific capabilities ty...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters